ProJenX

‌

ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways. The company was founded in 2021 and is headquartered in Nissequogue, New York.

Industries

Biotechnology, Health Care

Headquarters

New Suffolk, United States

Employees

1-10

Links

Org chart

Stan Abel

President and Chief Executive Officer

Collapse

Emily R. Lowry, Ph.D.

Scientific Co-Founder and Senior Scientific Advisor

Erin Fleming

Chief Operating Officer

Teams

This company has no teams yet

Offices

HQ
0 people · 0 jobs

Similar companies

Merck

285 followers

Amgen

282 followers

Revvity

10 followers

AtriCure

4 followers

Abbott

384 followers

Gilead Sciences

161 followers

Regeneron

132 followers

Illumina

79 followers

Agilent Technologies

82 followers

Apollo Global Management

46 followers

Verily Life Sciences

45 followers

Explore companies